Literature DB >> 22839656

Early induction of hypothermia for evacuated intracranial hematomas: a post hoc analysis of two clinical trials.

Guy L Clifton1, Christopher S Coffey, Sierra Fourwinds, David Zygun, Alex Valadka, Kenneth R Smith, Melisa L Frisby, Richard D Bucholz, Elisabeth A Wilde, Harvey S Levin, David O Okonkwo.   

Abstract

OBJECT: The authors hypothesized that cooling before evacuation of traumatic intracranial hematomas protects the brain from reperfusion injury and, if so, further hypothesized that hypothermia induction before or soon after craniotomy should be associated with improved outcomes.
METHODS: The National Acute Brain Injury Study: Hypothermia I (NABIS:H I) was a randomized multicenter clinical trial of 392 patients with severe brain injury treated using normothermia or hypothermia for 48 hours with patients reaching 33°C at 8.4 ± 3 hours after injury. The National Acute Brain Injury Study: Hypothermia II (NABIS:H II) was a randomized, multicenter clinical trial of 97 patients with severe brain injury treated with normothermia or hypothermia for 48 hours with patients reaching 35°C within 2.6 ± 1.2 hours and 33°C within 4.4 ± 1.5 hours of injury. Entry and exclusion criteria, management, and outcome measures in the 2 trials were similar.
RESULTS: In NABIS:H II among the patients with evacuated intracranial hematomas, outcome was poor (severe disability, vegetative state, or death) in 5 of 15 patients in the hypothermia group and in 9 of 13 patients in the normothermia group (relative risk 0.44, 95% CI 0.22-0.88; p = 0.02). All patients randomized to hypothermia reached 35°C within 1.5 hours after surgery start and 33°C within 5.55 hours. Applying these criteria to NABIS:H I, 31 of 54 hypothermia-treated patients reached a temperature of 35°C or lower within 1.5 hours after surgery start time, and the remaining 23 patients reached 35°C at later time points. Outcome was poor in 14 (45%) of 31 patients reaching 35°C within 1.5 hours of surgery, in 14 (61%) of 23 patients reaching 35°C more than 1.5 hours of surgery, and in 35 (60%) of 58 patients in the normothermia group (relative risk 0.74, 95%, CI 0.49-1.13; p = 0.16). A meta-analysis of 46 patients with hematomas in both trials who reached 35°C within 1.5 hours of surgery start showed a significantly reduced rate of poor outcomes (41%) compared with 94 patients treated with hypothermia who did not reach 35°C within that time and patients treated at normothermia (62%, p = 0.009).
CONCLUSIONS: Induction of hypothermia to 35°C before or soon after craniotomy with maintenance at 33°C for 48 hours thereafter may improve outcome of patients with hematomas and severe traumatic brain injury. Clinical trial registration no.: NCT00178711.

Entities:  

Mesh:

Year:  2012        PMID: 22839656     DOI: 10.3171/2012.6.JNS111690

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  24 in total

Review 1.  Severe Cranioencephalic Trauma: Prehospital Care, Surgical Management and Multimodal Monitoring.

Authors:  Luis Rafael Moscote-Salazar; Andres M Rubiano; Hernando Raphael Alvis-Miranda; Willem Calderon-Miranda; Gabriel Alcala-Cerra; Marco Antonio Blancas Rivera; Amit Agrawal
Journal:  Bull Emerg Trauma       Date:  2016-01

Review 2.  Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.

Authors:  Fan Chen; Zhifeng Qi; Yuming Luo; Taylor Hinchliffe; Guanghong Ding; Ying Xia; Xunming Ji
Journal:  Prog Neurobiol       Date:  2014-01-07       Impact factor: 11.685

Review 3.  Intraoperative Targeted Temperature Management in Acute Brain and Spinal Cord Injury.

Authors:  Jacqueline Kraft; Anna Karpenko; Fred Rincon
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

Review 4.  The use of targeted temperature management for elevated intracranial pressure.

Authors:  Jesse J Corry
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

5.  Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Jonathan Miller; Barry J Hoffer; Nigel H Greig; Chaim G Pick
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

6.  Diverse effects of hypothermia therapy in patients with severe traumatic brain injury based on the computed tomography classification of the traumatic coma data bank.

Authors:  Eiichi Suehiro; Hiroyasu Koizumi; Hirosuke Fujisawa; Motoki Fujita; Tadashi Kaneko; Yasutaka Oda; Susumu Yamashita; Ryosuke Tsuruta; Tsuyoshi Maekawa; Michiyasu Suzuki
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

Review 7.  Animal models of traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Nat Rev Neurosci       Date:  2013-02       Impact factor: 34.870

8.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

9.  Therapeutic effects of pharmacologically induced hypothermia against traumatic brain injury in mice.

Authors:  Jin Hwan Lee; Ling Wei; Xiaohuan Gu; Zheng Wei; Thomas A Dix; Shan Ping Yu
Journal:  J Neurotrauma       Date:  2014-07-07       Impact factor: 5.269

Review 10.  A Systematic Review of the Effects of Body Temperature on Outcome After Adult Traumatic Brain Injury.

Authors:  Lori Kennedy Madden; Holli A DeVon
Journal:  J Neurosci Nurs       Date:  2015-08       Impact factor: 1.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.